Sonia Hernández-Díaz, MD, DrPH

  • 4Articles
  • 43.5KReads1
  • 2015–2023Active
  • 31Collaborators
  • 57Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Sonia Hernández-Díaz, MD, DrPH, is affiliated with the Department of Epidemiology at Harvard T.H. Chan School of Public Health in Boston, Massachusetts. Her publications focus on reproductive safety and epidemiology, particularly concerning the use of second-generation antipsychotics during pregnancy and their implications for women with bipolar disorder. She has contributed to establishing and analyzing data from national pregnancy registries related to psychiatric medication exposure. Her work has been published in Psychiatrist.com between 2015 and 2023.

Publications

JCP
Atomoxetine and Prevalence of Major Congenital Malformations
Original Research

Atomoxetine and Prevalence of Major Congenital Malformations

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ January 16, 2023

Little is known about the safety of atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder. This study assessed the prevalence of major congenital malformations after first-trimester exposure to atomoxetine.
, , , et al
JCP
Correction

Correction. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

October 5, 2021

, , , et al
JCP
Reproductive Safety of Second-Generation Antipsychotics
Original Research

Reproductive Safety of Second-Generation Antipsychotics

August 3, 2021

What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?
, , , et al
JCP
Article

Establishment of the National Pregnancy Registry for Atypical Antipsychotics

April 22, 2015

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe